ISS VII: The Role of Homologous Recombination Deficiency in Precision Medicine

MTCC: 701

This symposium is supported by Myriad.

Moderator:
Sharyn N. Lewin, MD, FACS, FACOG, Holy Name Medical Center – Regional Cancer Center, Teaneck, NJ

Faculty:
Faith Zaslavsky, Myriad Genetic Laboratories, Salt Lake City, UT
Jeff Kofford, Myriad Genetic Laboratories, Ogden, UT
Mikael Barmore, Myriad Genetic Laboratories, Salt Lake City, UT
Shelly Cummings, Myriad Genetic Laboratories, Salt Lake City, UT
Tina Johnson, Myriad Genetic Laboratories, Salt Lake City, UT

Description:
This course will provide a background on Myriad Genetics’ newly FDA approved companion diagnostic myChoice CDx. We will discuss DNA repair pathways, focusing specifically on homologous recombination deficiency, with the effects it has on the genome and a few known causes of it. Expound upon the importance of gene sequencing, along with tumor testing as part of your diagnostic workup. We will cover in detail what sets myChoice CDx apart – it uses two individual methods, which include 3 biomarkers.

Top